Mymetics Corp (MYMX)

[Work Harder]

Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising New Candidate for Coronavirus

https://www.biospace.com/article/releases/airway-therapeutics-and-celonic-group-collaborate-to-produce-at-100-as-promising-new-candidate-for-coronavirus/

Marc Salzberg, MD
President & CEO

He spent several years at Roche’s headquarters in Basel, Switzerland as well as its affiliate in Toronto, Canada. As Head of Clinical Cancer Research at the Basel University, he co-founded and managed a clinical research network in Switzerland (CCRC).

During his career, Marc has successfully managed the growth and acquisition of two contract research organizations benefitting shareholders. He was a founder and President of Pharma Brains, a European boutique CRO, which has been acquired by Medpace, a US based global CRO, after 10 years of successful growth under his leadership. He then served as Vice President of Medical Affairs at Medpace.

Marc earned his Medical Doctorate degree from the University of Basel, Switzerland. His medical training and practice include pediatrics/ neonatology and oncology.

Michael Hellerstein
Vice President Regulatory Affairs & Quality

Mr. Hellerstein serves as Vice President of Regulatory and Quality at Airway Therapeutics. He has more than 20 years of experience in the life science industry combining a focus on regulatory and quality with broad experience across multiple disciplines of biotech product development. Trained as a molecular biologist, Mr. Hellerstein initially worked in drug discovery and then transitioned into quality, regulatory, and management roles. He worked for 15 years at GeoVax, where he designed and implemented the systems needed to advance vaccines from discovery through clinical trials and his responsibilities grew from method development lead to head of regulatory affairs, quality assurance and control, project management, outsourcing, and government contracting. He has also held positions at Cell Signaling Technology, Pfizer, Blue Sky Biotech, and Kiel Laboratories. Mr. Hellerstein graduated from Harvard University in 1999.

https://www.airwaytherapeutics.com/about-us/

Small world

LOL